12.07.2015 Views

high-alert - Department of Nursing

high-alert - Department of Nursing

high-alert - Department of Nursing

SHOW MORE
SHOW LESS
  • No tags were found...

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Connecticut Children’s Medical Center - Policy and Procedure ManualMedication Management Date Effective: May 09, 2011High-Alert Medications Date <strong>of</strong> Origin: February 01, 2005Approved By: Pharmacy and TherapeuticsCommittee, Clinical CouncilDate Approved: May 04, 2011Appendix AConnecticut Children’s High Alert MedicationsInsulinAspartGlargineLenteLisproNPHRegularInsulin CombinationsLispro 75/25NovoLIN 70/30NovoLOG 70/30Antiarrhythmics IVAmiodaroneBreTYLIUMLidocainePhenytoin or FosphenytoinProcainamideVerapamilAnti-CoagulantsAnticoagulant CitrateDextrose AEnoxaparinhePARIN (systemic therapy)WarfarinEpidural MedicationsAny medication by this routeThrombolytic Agents(systemic or regional therapy)AlteplaseUrokinaseCardiac GlycosideDigoxinVasoactive Agents, IVAtenololDOBUTamineDOPamineePHEDrineEPINEPHrineEsmololhydrALAzineIsoproterenolLabetalolMilrinoneniCARdipineNitroprussideNorepinephrinePhentolaminePhenylephrinePropranololTerbutalineNeuromuscular BlockingAgentsCisatracuriumPancuroniumRocuroniumSuccinylcholineVecuroniumIntravenous ElectrolyteBolusCalciumMagnesiumPhosphate SaltsPotassiumIntravenous FluidsSodium Chloride (greaterthan 0.9%)Potassium (greater or equalto 60 mEq/L)Total Parenteral Nutritionand IntralipidsNarcotic Agonists forContinuous Infusion orPCA UsefentaNYLhydroMORphoneMeperidineMethadonemorPHINESedative for ContinuousInfusionDexmedetomidineMidazolamProp<strong>of</strong>olBarbituratePENTobarbitalPHENobarbitalPage 4 <strong>of</strong> 5


Connecticut Children’s Medical Center - Policy and Procedure ManualMedication Management Date Effective: May 09, 2011High-Alert Medications Date <strong>of</strong> Origin: February 01, 2005Approved By: Pharmacy and TherapeuticsCommittee, Clinical CouncilDate Approved: May 04, 2011Appendix BAntineoplastic AgentsAsparaginaseAzaCITIDineArsenic trioxodeBleomycinBusulfanCARBOplatinCarmustinChlorambucilCISplatinCl<strong>of</strong>arabineCyclophosphamideCytarabineDacarbazineDactinomycinDAUNOrubicinDOXOrubicinEtoposideFludarabineFluorouracilGemtuzumabHydroxyureaIdarubicinIfosfamideLomustineMelphalanMercaptopurineMethotrexateMitomycinMitoxantroneMitotanePaclitaxelPegaspargaseriTUXimabThioguanineTopotecanThiotepaVinblastineVincristineVinorelbinePage 5 <strong>of</strong> 5

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!